SURGICAL RESULTS OF THE AORTOILIOFEMORAL OCCLUSIVE DISEASE, RISK FACTORS AND MID TERM FOLLOW-UP

Methods: Between March 2001 and December 2005, 133 elective patients were operated in our clinic owing to aortoiliofemoral occlusive disease. There were 128 men and 5 women. The mean age of the patients were 59.78±9.47 years (range,36 to 85 years). All patients were evaluated with history and physical examination of the patients, Doppler ultrasound examination of the carotis and lower extremity arteries, coronary angiography, and aortoiliac and lower extremity arteriography.

Results: The comorbid diseases and risk factors were smoking (n=97;72.9%), coronary artery disease (n=78;58.6%), hypertension (n=33;24.8%), hyperlipidemia (n=17;12.7%), diabetes mellitus (n=15; 11.2%), chronic obstructive pulmonary disease (n=13;9.8%), and renal disease (n=7;5%). A total of 35 patients (26%) underwent coronary artery bypass grafting (n=27;20%) or percutaneous transluminal coronary angioplasty (n=8;6%) before being performed surgical treatment of the aortoiliofemoral occlusive disease. Sixty-nine patients (51.8%) underwent to aortobifemoral bypass graft, 34 patients (25.5%) to aortofemoral bypass graft, 17 patients (12.7%) to iliofemoral bypass graft, 9 patients (6.7%) to extraanatomic bypass graft, 2 patients (1.5%) to aortobiiliac bypass graft, end 2 patients (1.5%) to aortoiliac bypass graft. Nineteen patients (14.2%) were also performed simultaneous femoropopliteal bypass graft. Mean follow-up was 13.8 months (range, 3 to 58 monts). The overall mortality rate was 2.2%. Overall patency and limb salvage rates was 99.3%.

Conclusion: Surgical reconstruction of aortoiliofemoral occlusive disease is a safe method with good middle-term results in patency and limb salvage rates and has low risk in the selected patients. (Turkish J Vasc Surg 2006;15(3):25-29).